PE Firm to Invest Up to $300 Million into UK Pharma Vertice Pharma
Nov 17 Private equity firm Warburg Pincus LLC said on Tuesday it had agreed to invest up to $300 million in Vertice Pharma, a British pharmaceuticals company that will focus on buying drug makers and their products.
Vertice Pharma will be a partnership between Warburg Pincus and two pharmaceutical executives, the private equity firm said in a statement.
Among its first acquisitions, Vertice has struck a deal to buy VistaPharm, a specialized manufacturer of pain medication, Warburg Pincus said, without disclosing the details of the transaction.
Help employers find you! Check out all the jobs and post your resume.
Vertice Pharma will be a partnership between Warburg Pincus and two pharmaceutical executives, the private equity firm said in a statement.
Among its first acquisitions, Vertice has struck a deal to buy VistaPharm, a specialized manufacturer of pain medication, Warburg Pincus said, without disclosing the details of the transaction.
Help employers find you! Check out all the jobs and post your resume.